MYC and cancer: Cancers defined by mutations in FBW7 (which disrupt the association of FBW7 with the CPD-client protein) are characterized by elevated levels of the CPD-client oncoproteins MYC [31], c-Jun [32], cyclin E [33] and NOTCH [34].